|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.73 USD | -0.36% |
|
-35.20% | -30.82% |
| 07-10 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| 07-10 | Ionis Pharmaceuticals Reaffirms Fiscal 2026 Financial Guidance | MT |
| Market Cap | 9.04B 7.91B 7.29B 6.71B 12.71B 870B 12.92B 87.09B 34.17B 425B 33.97B 33.22B 1,466B | P/E 2026 * |
-15.1x | P/E 2027 * | -31x |
|---|---|---|---|---|---|
| Enterprise Value | 8.79B 7.69B 7.09B 6.52B 12.35B 846B 12.56B 84.66B 33.22B 414B 33.02B 32.3B 1,425B | EV / Sales 2026 * |
9.89x | EV / Sales 2027 * | 6.41x |
| Free-Float |
99.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | -0.36% | ||
| 1 week | -35.20% | ||
| Current month | -30.97% | ||
| 1 month | -26.00% | ||
| 3 months | -28.76% | ||
| 6 months | -29.12% | ||
| Current year | -30.82% |
| 1 week | 53.51 |  | 64.44 |
| 1 month | 53.51 | | 86.74 |
| Current year | 53.51 | | 86.74 |
| 1 year | 40.03 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 2012-06-30 |
Brett Monia
CEO | Chief Executive Officer | 64 | 2019-12-31 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 2000-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 2005-12-12 |
| Director/Board Member | 73 | 2002-04-30 | |
Brett Monia
BRD | Director/Board Member | 64 | 2019-03-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Fiscal year | Director | 42,224 | 0.0255% | ||
| 06-30 | Free | Director | 7,670 | 0.0046% | ||
| 06-30 | Free | Director | 7,670 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -35.20% | +30.31% | +28.84% | 9.04B | |
| -2.03% | -1.92% | +0.28% | +5.58% | 50.35B | |
| -0.29% | -2.81% | +387.81% | +591.82% | 39.21B | |
| -0.49% | +1.48% | +31.16% | -6.46% | 34.52B | |
| +1.53% | +3.11% | +15.41% | +58.54% | 34.6B | |
| +1.68% | -0.62% | +3.30% | +27.34% | 27.05B | |
| +1.13% | -3.11% | - | - | 16.68B | |
| -1.29% | -0.52% | +69.24% | +117.60% | 15.11B | |
| -0.61% | +0.12% | +13.93% | +17.26% | 13.85B | |
| +2.45% | +3.99% | +18.20% | -30.12% | 13.18B | |
| Average | +0.17% | -2.68% | +63.29% | +90.04% | 25.36B | |
| Weighted average by Cap. | -0.05% | -0.46% | +78.81% | +117.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 889M 777M 717M 659M 1.25B 85.55B 1.27B 8.56B 3.36B 41.82B 3.34B 3.27B 144B | 1.4B 1.22B 1.13B 1.04B 1.96B 135B 2B 13.46B 5.28B 65.77B 5.25B 5.14B 227B |
| Net income | -596M -521M -480M -442M -837M -57.32B -851M -5.74B -2.25B -28.02B -2.24B -2.19B -96.57B | -296M -259M -239M -220M -416M -28.52B -423M -2.85B -1.12B -13.94B -1.11B -1.09B -48.05B |
| Net Debt | -252M -221M -204M -187M -355M -24.29B -361M -2.43B -954M -11.87B -948M -927M -40.93B | -86.16M -75.33M -69.49M -63.88M -121M -8.29B -123M -830M -326M -4.05B -324M -316M -13.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | US$54.73 | -0.36% | 3,577,545 |
| 26-07-14 | US$54.93 | -3.21% | 4,700,265 |
| 26-07-13 | US$56.75 | -2.58% | 5,097,949 |
| 26-07-10 | US$58.25 | -9.37% | 11,444,106 |
| 26-07-09 | US$64.27 | -23.90% | 20,447,626 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
